|
TIME
|
SUBJECT
|
SPEAKER
|
| 08.30-09.15
am |
Registration
|
|
| 09.15-09.30
am |
Welcome
& Introduction |
K.A.Dinshaw |
| SESSION
I A |
OSTEOSARCOMA
|
Chairperson:
S Rastogi
Moderator: M.G.Agarwal |
| 09.30-10.00
am |
Surgery:
Adequacy & Impact on Survival |
R.Grimer |
| 10.00-10.30
am |
Follow-up
& Management of Pulmonary Mets. |
B.Rao |
| 10.30-11.00
am |
Chemotherapy:
Which, When, & How much? |
M.Paulussen
|
| 11.00-11.15
am |
Discussion
& Moderators Consensus
|
|
| 11.15-11.30
am |
COFFEE
BREAK
|
|
| SESSION
I B |
APPLICABILITY
OF EVIDENCE IN
THE INDIAN SCENARIO
|
Chairperson:
M.Paulussen
Moderator: A.Puri |
| 11.30-11.45
am |
Pathology |
N.A.Jambhekar |
| 11.45-12.00
am |
Chemotherapy |
S.K.Pai |
| 12.00-12.15
am |
Surgery |
M.G.Agarwal |
| 12.15-12.45
pm |
Discussion
& Moderators Consensus |
|
| 12.45
- 01.30 pm |
LUNCH
|
|
| SESSION
II A |
EWING’S
SARCOMA/ PNET
|
Chairperson:
B.Rao
Moderator: S.Laskar |
| 01.30-02.00
pm |
Chemotherapy:
What is optimum? |
M.Paulussen |
| 02.00-02.30
pm |
Surgery:
What is optimum? |
R.Grimer |
| 02.30-03.00
pm |
Radiotherapy:
What is optimum? |
R
Taylor |
| 03.00-03.30
pm |
Discussion
& Moderators Consensus
|
|
| SESSION
II B |
APPLICABILITY
OF EVIDENCE IN
THE INDIAN SCENARIO
|
Chairperson:
S.C.Sharma
Moderator: P.M.Parikh |
| 03.30-03.45
pm |
Chemotherapy |
C.N.Nair |
| 03.45-04.00
pm |
Surgery |
A.Puri |
| 04.00-04.15
pm |
Radiotherapy |
M.A.Muckaden |
| 04.15-04.30
pm |
Discussion
& Moderators Consensus
|
|
| 04.30-04.45
pm |
COFFEE
BREAK
|
|
| SESSION
III |
SOFT
TISSUE SARCOMA
|
Chairperson:
S.K.Shrivastava
Moderator: R.A Badwe |
| 04.45-05.05
pm |
Surgery |
B.Rao |
| 05.05-05.25
pm |
Radiotherapy |
S.Laskar |
| 05.25-05.45
pm |
Chemotherapy |
S.Gupta
|
| 05.45-06.00
pm |
Discussion
& Moderators Consensus
|
|
| TIME |
SUBJECT |
SPEAKER |
| 08.30-09.00
am |
Registration |
|
| SESSION
I |
Overview
of Round Cell Tumors |
Chairperson:
R.F.Chinoy
Moderator: P.Kurkure |
| 09.00-09.25
am |
Round
Cell Tumors: Pathologists Persrective |
T.Seth |
| 09.25-09.50
am |
Clinical
Approach to Undifferentiated RCT |
R.Pinkerton |
| 09.50-10.00
am |
Discussion
& Moderators Consensus |
|
| SESSION
II |
RHABDOMYOSARCOMA |
Chairperson:
R.Taylor
Moderator: S.Kanvinde |
| 10.00-10.15
am |
Variants
of RMS & Clinical Relevance |
R.F.Chinoy |
| 10.15-10.35
am |
Chemotherapy
for Rhabdomyosarcoma |
M.Paulussen |
| 10.35-10.55
am |
Surgery
for Rhabdomyosarcoma |
B.Rao |
| 10.55-11.15
am |
Radiotherapy
for Rhabdomyosarcoma |
J.Kalapurakal
|
| 11.15-11.30
am |
Discussion
& Moderators Consensus |
|
| 11.30-12.00
am |
COFFEE
BREAK |
|
| 12.00am-01.00pm |
"HOSPITAL
DAY ORATION" |
Tom
DeMeester |
| 01.00-01.45
pm |
LUNCH |
|
| SESSION
III |
BRAIN
TUMORS |
Chairperson:
B.C.Goswami
Moderator: R.Sarin |
| 01.45-02.15
pm |
RT
in Medulloblastoma: How much dose to How much volume |
R.Taylor |
| 02.15-02.35
pm |
Role
of Chemotherapy in Medulloblastoma / PNET |
S.Khatua |
| 02.35-02.50
pm |
Consensus
Guidelines for Medulloblastoma |
|
| 02.50-03.10
pm |
Management
of Sellar/ Suprasellar Tumors |
R.Sarin |
| 03.10-03.30
pm |
Evidence
based guidelines for pediatric Gliomas |
R.Jalali |
| 03.30-03.45
pm |
Consensus
Guidelines for Gliomas |
|
| 03.45-04.00
pm |
COFFEE
BREAK |
|
| SESSION
IV |
RETINOBLASTOMA |
Chairperson:
A.Kapadia
Moderator: M.A.Muckaden |
| 04.00-04.20
pm |
Genesis
of Retinoblastoma: Biological & Clinical Significance |
P.Amre |
| 04.20-04.40
pm |
Ophthalmological
Evaluation & Staging |
A.Malpani
|
| 04.40-05.00
pm |
Chemotherapy:
The Current Status |
S.Banavali |
| 05.00-05.20
pm |
Discussion
& Moderators Consensus |
|
|
TIME
|
SUBJECT
|
SPEAKER
|
| 08.30-09.00
am |
Registration
|
|
| SESSION
I |
CANCER
OESOPHAGUS
|
Chairperson:
PB Deasi
Moderator: K Mohandas |
| 09:00am-09:15am |
Epidemiology:
Changing trend |
K
Mohandas |
| 09:15am-09:30am |
Investigations:
Diagnostic & Staging |
S
Mehta |
| 09:30am-10:00
am |
Role
of surgery: Evidence based management strategies |
T
Demeester |
| 10:00am-10:15am |
Ideal
Pathology Report |
N
Jambhekar |
| 10:15am-10:30am |
Role
of radiation therapy |
S
C Sharma |
| 10:30am-10:45am |
Role
of Chemotherapy: Review of published literature |
R
Mistry |
| 10:45am-11:00am |
Palliation
for cancer oesophagus: What is the best approach? |
V Dhir
|
| 11:00am-11:30am |
Discussion
& Moderators Consensus
|
|
| 11:30am-12:00am |
COFFEE
BREAK
|
|
| 12.00am-01.00pm |
“HOSPITAL
DAY ORATION”
|
Tom
DeMeester |
| 01.00-01.45
pm |
LUNCH
|
|
| SESSION
II |
CANCER
LUNG
|
Chairperson:
R A Badwe
Moderator: J P Agarwal |
| 1:45
pm-2:15 pm |
Screening
for lung cancer |
A
Miller |
| 2:15
pm-2:30 pm |
Staging
: Role of Imaging |
S
Juvekar |
| 2:30
pm-2:45 pm |
Staging
: Role of Mediastinoscopy |
R
Mistry |
| 2:45
pm-3:00 pm |
Staging
: Role of PET scan |
N
Nair |
| 3:00
pm-3:20 pm |
Surgery
for lung cancer |
RK
Deshpande |
| 3:20
pm-3:30 pm |
Ideal
pathology report |
N
Jambheker |
| 3:
30 pm-4:00 pm |
Discussion
& Moderators Consensus |
|
| 4:00
pm-4:15 pm |
COFFEE
BREAK
|
|
| SESSION
III |
|
Chairperson:
S K Shrivastava
Moderator: S Gupta |
| 4:
15 pm-4:30 pm |
Role
of Radiation therapy
|
G
V Giri |
| 4:30
pm-4:45 pm |
Adjuvant
Chemotherapy for lung cancer |
T
Sagar |
| 4:45
pm-5:00 pm |
Chemotherapy
for Stage III lung cancer |
P
M Parikh |
| 5:00
pm-5:15 pm |
Chemotherapy
for palliation |
P
Shah
|
| 5:15
pm-5:45 pm |
Discussion
& Moderators Consensus
|
|
| TIME |
SUBJECT |
SPEAKER |
| 08.30-09.00
am |
Registration
|
|
| SESSION
I |
NEUROBLASTOMA
|
Chairperson:
S.Karmarkar
Moderator: G.Kapoor |
| 09.00-09.30
am |
Risk
Based Management of Neuroblastoma |
R.Pinkerton
|
| 09.30-09.50
am |
Surgery
in Advanced Neuroblastoma |
B.Rao |
| 09.50-11.05
am |
MIBG
versus Radiotherapy in Neuroblastoma |
J.Kalapurakal |
| 11.05-11.15
am |
Applicability
in the Indian Scenario |
P.Kurkure |
| 10.15-11.30
am |
Discussion
& Moderators Consensus
|
|
| 11.30-11.45
am |
COFFEE
BREAK
|
|
| SESSION
II |
WILMS
TUMOR
|
Chairperson:
HB Tongaonkar
Moderator: R H Ramadwar |
|
11.45-12.15 am |
North
American versus the European Approach |
J.Kalapurakal |
| 12.15-12.45
pm |
PANEL
DISCUSSION
APPLICABILITY
OF EVIDENCE IN
THE INDIAN SCENARIO
|
Panelists:
R Taylor (Radiotherapy)
P Kurkure (Paed. Oncology)
S Oak (Surgery) |
| 12.45-01.00
pm |
Discussion
& Moderators Consensus
|
|
| 01:00-01:30
pm |
Is
the Time right for Childhood Solid Tumor Study Group (CSTG)?
- Discussion |
P
Kurkure ( Discussant) |
| 01.30-02.00
pm |
LUNCH
|
|
|
SESSION
III
|
TECHNOLOGY
& LATE EFFECTS OF TREATMENT
|
Chairperson:
M Mangalani
Moderator: N.Huilgol |
| 02.00-02.40
pm |
High
Precision RT Techniques in Non-CNS Sites & Late Effects
of Radiotherapy in Children |
J.Kalapurakal |
| 02.40-03.10
pm |
Late
Effects of Chemotherapy in Children |
R.Pinkerton |
| 03.10-03.30
pm |
The
Tata Memorial Hospital Experience |
P.Kurkure |
| 03.30-04.00
pm |
Discussion
& Moderators Consensus
|
|
Preface